Clinical Trial: Full-Course ECMO Strategy for Moderate-to-Severe ARDS

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07726953) titled 'Full-Course ECMO Strategy for Moderate-to-Severe ARDS' on July 21.

Brief Summary: China faces major challenges in the ECMO management of patients with moderate-to-severe ARDS, including substantial heterogeneity in clinical practice, low weaning success rates, and high complication rates. A key underlying reason is the lack of a standardized full-course management pathway that is applicable to real-world clinical practice in China. This study focuses on the construction and evidence-based evaluation of a precision full-course ECMO management pathway for patients with moderate-to-severe ARDS, aiming to address fragmented care process...